Early Motor Experience for Down Syndrome
Trial Summary
The trial protocol does not specify whether participants need to stop taking their current medications.
Research shows that early physical therapy can help improve motor development in children with Down syndrome, especially when started before the age of one. Additionally, physical therapy has been found to benefit people with intellectual disabilities by improving their gross motor skills.
12345The research does not provide specific safety data for early motor experience therapy, but physical therapy interventions for improving motor skills are generally considered safe for people with intellectual disabilities and children with neurodevelopmental disorders.
24567The Early Motor Experience treatment for Down Syndrome is unique because it focuses on both gross and fine motor skills through physical therapy, starting at a very young age, which can help improve motor development and potentially lead to earlier independent walking. This approach is different from other treatments as it emphasizes early intervention and task-specific training, such as treadmill interventions, to address motor delays.
238910Eligibility Criteria
This trial is for infants aged 7-24 months who have been diagnosed with Down syndrome. It's not suitable for those with seizure disorders, uncorrectable vision or hearing issues, heart problems, or any severe medical conditions that would limit their participation.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Gross Motor Intervention
Participants receive a home-based, parent-administered body-weight supported treadmill intervention from about 10 months of age until walking onset
Gross and Fine Motor Intervention
Participants receive additional fine motor intervention using 'sticky mittens' from about 10 months of age for five months
Follow-up
Participants are monitored for safety and effectiveness after treatment
Participant Groups
Gross and fine motor intervention is already approved in United States, European Union for the following indications:
- Motor Development Delay
- Cognitive Development Delay
- Language Development Delay
- Down Syndrome
- Motor Skill Development
- Cognitive and Language Development